Schweizer A

References (11)

Title : Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans - Ahren_2011_Diabetes.Obes.Metab_13_775
Author(s) : Ahren B , Schweizer A , Dejager S , Villhauer EB , Dunning BE , Foley JE
Ref : Diabetes Obes Metab , 13 :775 , 2011
Abstract :
PubMedSearch : Ahren_2011_Diabetes.Obes.Metab_13_775
PubMedID: 21507182

Title : Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as Isoglycemic Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes - Vardarli_2011_J.Clin.Endocrinol.Metab_96_945
Author(s) : Vardarli I , Nauck MA , Kothe LD , Deacon CF , Holst JJ , Schweizer A , Foley JE
Ref : J Clinical Endocrinology Metab , 96 :945 , 2011
Abstract :
PubMedSearch : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945
PubMedID: 21239518

Title : An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials - Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495
Author(s) : Ligueros-Saylan M , Foley JE , Schweizer A , Couturier A , Kothny W
Ref : Diabetes Obes Metab , 12 :495 , 2010
Abstract :
PubMedSearch : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495
PubMedID: 20518805

Title : Role of vildagliptin in managing type 2 diabetes mellitus in the elderly - Halimi_2010_Curr.Med.Res.Opin_26_1647
Author(s) : Halimi S , Raccah D , Schweizer A , Dejager S
Ref : Curr Med Res Opin , 26 :1647 , 2010
Abstract :
PubMedSearch : Halimi_2010_Curr.Med.Res.Opin_26_1647
PubMedID: 20441397

Title : Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes - Ahren_2009_J.Clin.Endocrinol.Metab_94_1236
Author(s) : Ahren B , Schweizer A , Dejager S , Dunning BE , Nilsson PM , Persson M , Foley JE
Ref : J Clinical Endocrinology Metab , 94 :1236 , 2009
Abstract :
PubMedSearch : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236
PubMedID: 19174497

Title : Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet - Halimi_2008_Vasc.Health.Risk.Manag_4_481
Author(s) : Halimi S , Schweizer A , Minic B , Foley J , Dejager S
Ref : Vasc Health Risk Manag , 4 :481 , 2008
Abstract :
PubMedSearch : Halimi_2008_Vasc.Health.Risk.Manag_4_481
PubMedID: 18827867

Title : Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study - Garber_2007_Diabetes.Obes.Metab_9_166
Author(s) : Garber AJ , Schweizer A , Baron MA , Rochotte E , Dejager S
Ref : Diabetes Obes Metab , 9 :166 , 2007
Abstract :
PubMedSearch : Garber_2007_Diabetes.Obes.Metab_9_166
PubMedID: 17300592

Title : The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion - El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165
Author(s) : El-Ouaghlidi A , Rehring E , Holst JJ , Schweizer A , Foley J , Holmes D , Nauck MA
Ref : J Clinical Endocrinology Metab , 92 :4165 , 2007
Abstract :
PubMedSearch : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165
PubMedID: 17698900

Title : Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes - Fonseca_2007_Diabetologia_50_1148
Author(s) : Fonseca V , Schweizer A , Albrecht D , Baron MA , Chang I , Dejager S
Ref : Diabetologia , 50 :1148 , 2007
Abstract :
PubMedSearch : Fonseca_2007_Diabetologia_50_1148
PubMedID: 17387446

Title : Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year - Ahren_2005_Diabetes.Care_28_1936
Author(s) : Ahren B , Pacini G , Foley JE , Schweizer A
Ref : Diabetes Care , 28 :1936 , 2005
Abstract :
PubMedSearch : Ahren_2005_Diabetes.Care_28_1936
PubMedID: 16043735

Title : Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes - Ahren_2004_Diabetes.Care_27_2874
Author(s) : Ahren B , Gomis R , Standl E , Mills D , Schweizer A
Ref : Diabetes Care , 27 :2874 , 2004
Abstract :
PubMedSearch : Ahren_2004_Diabetes.Care_27_2874
PubMedID: 15562200